This is a match-making section for JPIAMR 16th call -AMR diagnostics and surveillance 2023 (DISTOMOS).
Human Health
Animal Health (incl. wild-life, livestock, acquatic organisms, and companion animals)AMR DIAGNOSTICS RAPID TEST POC RESISTANCE GENES HUMAND & VETERINARY
Created in France by pioneers in in vitro rapid diagnostic tests, NG Biotech has leveraged the Lateral Flow Immunochromatography (LFIA) to become a leading expert in the field of rapid tests for AMR and infectious diseases. NG Biotech has developed a range of Antimicrobial Resistance (AMR), rapid tests including the only multiplex LFIA test (NG-Test® CARBA-5) for the detection and differentiation of the five most prevalent carbapenemase families (KPC, OXA-48-like, VIM, IMP and NDM) and their most clinically relevant variants in less than 15 minutes in a single cassette. Our current product range includes tests to detect ESBL resistance (NG-Test® CTX-M MULTI) and Colistin resistance (NG-Test® MCR-1). With our renowned network, our rapid tests, fully developed and produced in France, are distributed worldwide in more than 70 countries and we have developed a proprietary patented immunoassay platform which can be tailored for your projects We are also an active member of the BEAM Alliance
We are open to participate in any project where we can use our existing technology and improve our range of rapid tests for the detection of AMR genes/resistance, therefore supporting " improve existing strategies, technologies or methods, or data use strategies to support One Health AMR surveillance”.
Submitted on 2023-01-24 17:04:13
« Return to the partner search tool